 JERUSALEM , Nov. 3, 2022 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV BiondVax, a biotechnology company focused on developing, manufacturing, and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, announced today that Dr. Dalit Weinstein Fischer , BiondVaxs Head of Technical RD, will attend and present at Recent Advances in Fermentation Technology RAFT 14, a conference of the Society for Industrial Microbiology and Biotechnology SIMB taking place November 6 to 9, 2022 in Orlando, Florida. 